Sangart Receives $50,737,293 New Round

  • Feed Type
  • Date
    5/25/2012
  • Company Name
    Sangart
  • Mailing Address
    6175 Lusk Blvd San Diego, CA 92121
  • Company Description
    Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.
  • Website
    http://www.sangart.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,737,293
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed